Metabolic Dysfunction-Associated Steatohepatitis Resources Chosen by Advanced Practice Providers
  • Clinical guidelines
  • Patient support and education resources
  • Research updates
Chronic liver disease (CLD) causes approximately two million deaths annually and presents a major global health burden. Because most severe outcomes—like liver failure, portal hypertension, and hepatocellular carcinoma—occur...

Nationwide Study Reveals High Burden of Liver Steatosis and Fibrosis in China’s Adult Population

This nationwide, population-based cross-sectional study aimed to assess the prevalence of liver steatosis and fibrosis in both the general population...
Miu Lai (Milly) Ng,
CURATED BY:
Miu Lai (Milly) Ng,
FNP-BC, MPH (Harvard)

Systemic Impacts of MASLD on Heart-related Diseases

This review provided a comprehensive analysis of the extrahepatic manifestations of metabolic dysfunction-associated steatohepatitis (MASH), focusing on chronic diseases related...
Chantil D. Jeffreys,
CURATED BY:
Chantil D. Jeffreys,
FNP, DNP, JD

Non-invasive Tests Show Promise for Identifying High-Risk MASH

This multicenter cross-sectional study evaluated the diagnostic performance of non-invasive tests (NITs) in detecting metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis...
Chantil D. Jeffreys,
CURATED BY:
Chantil D. Jeffreys,
FNP, DNP, JD

Physician Associate and Nurse Practitioner Contributors to the Metabolic Dysfunction-Associated Steatohepatitis Center of Excellence

POCN’s Metabolic Dysfunction-Associated Steatohepatitis Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Share